The predominant areas of cooperation between the 2 regulatory authorities embrace trade of security info, together with pharmacovigilance the place there’s a explicit security concern associated to the opposite celebration.
“The MoU will help in establishing a framework for fruitful cooperation and exchange of information between the CDSCO and the UK MHRA in matters relating to medical products regulation in line with their international responsibilities,” the assertion issued on Wednesday stated.
The different areas of cooperation embrace participation in scientific and sensible conferences, symposia, seminars and fora organised by India and the United Kingdom, trade of knowledge and cooperation on good laboratory practices, good medical practices, good manufacturing practices, good distribution practices and good pharmacovigilance practices, and capability constructing in mutually agreed areas.
The settlement goals to advertise an understanding between the events of one another’s regulatory framework, necessities and processes and to facilitate future regulatory strengthening initiatives for each.
It additionally contains trade of knowledge on legal guidelines and rules relating to medicines and medical gadgets and knowledge trade to assist efforts to manage unlicensed exports.
“It would facilitate better understanding of the regulatory aspects between the two sides and could help in increased cooperation in the field of medical products regulation and better coordination in international fora,” the assertion stated.